01 1Pfizer Ireland Pharmaceuticals Unlimited Company
01 1Pfizer Korea
01 1Lolatinib
01 1U.S.A
Registrant Name : Pfizer Korea
Registration Date : 2021-11-30
Registration Number : Su87-30-ND
Manufacturer Name : Pfizer Ireland Pharmaceutica...
Manufacturer Address : Ringaskiddy API Plant, Ringaskiddy, Co. Cork, P43 X336, Ireland
90
PharmaCompass offers a list of Lorlatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lorlatinib manufacturer or Lorlatinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lorlatinib manufacturer or Lorlatinib supplier.
A Lorlatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lorlatinib, including repackagers and relabelers. The FDA regulates Lorlatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lorlatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lorlatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lorlatinib supplier is an individual or a company that provides Lorlatinib active pharmaceutical ingredient (API) or Lorlatinib finished formulations upon request. The Lorlatinib suppliers may include Lorlatinib API manufacturers, exporters, distributors and traders.
click here to find a list of Lorlatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lorlatinib Drug Master File in Korea (Lorlatinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lorlatinib. The MFDS reviews the Lorlatinib KDMF as part of the drug registration process and uses the information provided in the Lorlatinib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lorlatinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lorlatinib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lorlatinib suppliers with KDMF on PharmaCompass.
